Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for the quarter ended 30th June, 201809-08-2018
09-08-2018
Fixed Record Date As August 21, 2018 To Ascertain Shareholders For Payment Of Interim Dividend
Fixed Record date as August 21, 2018 to ascertain shareholders for payment of Interim Dividend08-08-2018
Board declares Interim Dividend
Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 08, 2018, inter alia, has approved the following :- Declaration of an interim dividend of Rs. 1.50 ps. per equity share of Rs. 2/- each (75%) for the financial year 2018-19. The said interim dividend pay-by-date is on or before August 27, 2018.08-08-2018
Financial Results For The Quarter Ended 30Th June, 2018
Financial Results for the quarter ended 30th June, 201808-08-2018
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The Company will host an Earnings Call with Investors / Analysts on Thursday, August 9, 2018 at 11.00 AM IST to disseminate Financial Results of the company for the quarter ended 30th June, 2018.01-08-2018
Board to consider Interim Dividend
Natco Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on August 08, 2018 to consider, among other things, the following items of businesses and related matters:1. Unaudited financial results for the quarter ended June 30, 2018 along with the Limited Review Report thereon.2. To Consider Interim Dividend, if any, for the year 2018-19....28-07-2018
Closure of Trading Window
Please further note that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 TRADING WINDOW for dealing in the securities of the Company will be closed from 30th July 2018 to 10th August 2018 (both days inclusive). Trading window will be opened from 11th August 2018.28-07-2018
Board Meeting Intimation for Board Meeting To Be Held On Wednesday 8Th August, 2018
NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2018 ,inter alias, to consider and approve 1. Unaudited financial results for the quarter ended 30th June, 2018 along with the Limited Review Report thereon. 2. To Consider Interim Dividend, if any, for the year 18-19. 3. Convening of 35th Annual General Meeting to be held for the financial year 2017-18.28-07-2018
Shareholding for the Period Ended June 30, 2018
Natco Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here05-07-2018